Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space ↗

October 23, 2023

Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.

Via Investor's Business Daily

Israeli-Hamas War: U.S. Exchange-Listed Israeli Stocks Continue To Decline ↗

October 22, 2023

The 111 Israeli companies with stocks trading on US exchanges have combined market caps over $150B. Or at least they did midweek: since the Hamas-Israeli War began October 7th, pretty much everything...

Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their...

Investor Exit Israel ETFs Following Attacks, But Remain Confident In Large-Caps ↗

October 19, 2023

Via Benzinga

Topics ETFs

Thoughts For Thursday: War Worries Rattle The Market ↗

October 19, 2023

111 Israeli companies trade on U.S. stock exchanges of which only 15 have market capitalization of $2B or more.

Hamas-Israeli War: US Exchange Listed Israeli Stocks Hit Hard ↗

October 18, 2023

Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder

October 17, 2023

Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict ↗

October 10, 2023

As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country is considering forming an emergency government.

Via Benzinga

Topics ETFs

Israeli Stocks Fall as Investors Fear Middle East Conflict ↗

October 09, 2023

The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks.

Via InvestorPlace

Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch ↗

October 09, 2023

Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.

Via Benzinga

Topics ETFs

Why Teva Pharmaceutical (TEVA) Stock Is Falling ↗

October 09, 2023

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares are trading lower by 2.7% to $9.17 Monday morning amid conflict in the company's home country, Israel.

Via Benzinga

Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names ↗

October 09, 2023

Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel.

Via Investor's Business Daily

Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023

October 06, 2023

Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories ↗

October 04, 2023

Benzinga

Via Benzinga

Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble. ↗

October 04, 2023

The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.

Via Investor's Business Daily

Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People ↗

October 04, 2023

Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and

Via Benzinga

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment

October 04, 2023

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

Teva Announces Changes to Executive Management Team

September 28, 2023

Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories ↗

September 27, 2023

Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO

Via Benzinga

Topics Artificial Intelligence

Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva ↗

September 27, 2023

A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T

Via Benzinga

Topics Intellectual Property

Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report ↗

September 26, 2023

Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...

Via Benzinga

3 No-Brainer Stocks to Buy With $20 Right Now ↗

September 13, 2023

You don't need a boatload of cash to begin growing your wealth on Wall Street.

Via The Motley Fool

Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US ↗

September 12, 2023

Last year, Teva Pharmaceutical Industries Ltd (NYSE: TEVA), the primary producer of Adderall, faced shortages

Via Benzinga

TEVA - A Pharma Stock To Watch ↗

September 11, 2023

TEVA is one of the few instruments that has handily cleared its July 6-month calendar range high. The 50 daily moving average is about to cross or golden cross the 200-DMA and enter a bullish phase.

How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug ↗

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 11, 2023

Via Benzinga

September 11, 2023

This story was first published on the Benzinga India portal.

Via Benzinga

Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug ↗

September 07, 2023

Bristol Myers Squibb Co (NYSE: BMY) faces fresh allegations in a recent lawsuit, accused of employing deceptive patents and illicit strategies to preserve its dominant position in the blood cancer drug...

Via Benzinga

Topics Intellectual Property Lawsuit

Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

September 06, 2023